ForFarmers Future Growth
Future criteria checks 3/6
ForFarmers is forecast to grow earnings and revenue by 21.3% and 1.6% per annum respectively. EPS is expected to decline by 48.6% per annum. Return on equity is forecast to be 4.3% in 3 years.
Key information
21.3%
Earnings growth rate
-48.6%
EPS growth rate
Food earnings growth | 10.1% |
Revenue growth rate | 1.6% |
Future return on equity | 4.3% |
Analyst coverage | Low |
Last updated | 01 Nov 2024 |
Recent future growth updates
Recent updates
ForFarmers (AMS:FFARM) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Aug 16Here's Why ForFarmers (AMS:FFARM) Has A Meaningful Debt Burden
May 03ForFarmers (AMS:FFARM) Has Announced That Its Dividend Will Be Reduced To €0.15
Mar 08ForFarmers (AMS:FFARM) Could Be Struggling To Allocate Capital
Jul 16ForFarmers (AMS:FFARM) Has Affirmed Its Dividend Of €0.29
Apr 13ForFarmers (AMS:FFARM) Has Announced A Dividend Of €0.29
Feb 27We Think ForFarmers (AMS:FFARM) Can Stay On Top Of Its Debt
Nov 30ForFarmers (AMS:FFARM) Could Be Struggling To Allocate Capital
Aug 19Is ForFarmers (AMS:FFARM) A Risky Investment?
May 10Tread With Caution Around ForFarmers N.V.'s (AMS:FFARM) 4.9% Dividend Yield
Apr 04What Type Of Returns Would ForFarmers'(AMS:FFARM) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Mar 16Are Investors Undervaluing ForFarmers N.V. (AMS:FFARM) By 45%?
Mar 01Here's Why ForFarmers's (AMS:FFARM) Statutory Earnings Are Arguably Too Conservative
Feb 01Does ForFarmers N.V.'s (AMS:FFARM) Weak Fundamentals Mean A Downturn In Its Stock Should Be Expected?
Jan 15What To Know Before Buying ForFarmers N.V. (AMS:FFARM) For Its Dividend
Dec 28We Think ForFarmers (AMS:FFARM) Can Manage Its Debt With Ease
Dec 15If You Had Bought ForFarmers' (AMS:FFARM) Shares Three Years Ago You Would Be Down 47%
Dec 01Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,833 | 28 | 38 | 80 | 2 |
12/31/2025 | 2,815 | 27 | 41 | 80 | 2 |
12/31/2024 | 2,754 | 18 | 51 | 46 | 2 |
6/30/2024 | 2,724 | 17 | 60 | 91 | N/A |
3/31/2024 | 2,849 | 8 | 56 | 89 | N/A |
12/31/2023 | 2,975 | -1 | 52 | 87 | N/A |
9/30/2023 | 3,149 | -4 | 47 | 82 | N/A |
6/30/2023 | 3,324 | -7 | 43 | 78 | N/A |
3/31/2023 | 3,320 | 5 | 28 | 63 | N/A |
12/31/2022 | 3,315 | 18 | 13 | 48 | N/A |
9/30/2022 | 3,134 | 15 | 7 | 42 | N/A |
6/30/2022 | 2,953 | 13 | 1 | 37 | N/A |
3/31/2022 | 2,812 | 12 | 8 | 46 | N/A |
12/31/2021 | 2,671 | 12 | 15 | 55 | N/A |
9/30/2021 | 2,582 | 9 | 33 | 74 | N/A |
6/30/2021 | 2,494 | 5 | 50 | 93 | N/A |
3/31/2021 | 2,423 | 10 | 56 | 96 | N/A |
12/31/2020 | 2,352 | 14 | 62 | 98 | N/A |
9/30/2020 | 2,357 | 21 | 68 | 102 | N/A |
6/30/2020 | 2,361 | 28 | 74 | 106 | N/A |
3/31/2020 | 2,412 | 23 | 67 | 101 | N/A |
12/31/2019 | 2,463 | 18 | 59 | 96 | N/A |
9/30/2019 | 2,500 | 25 | 31 | 71 | N/A |
6/30/2019 | 2,537 | 33 | 2 | 47 | N/A |
3/31/2019 | 2,471 | 46 | 20 | 64 | N/A |
12/31/2018 | 2,405 | 59 | 38 | 82 | N/A |
9/30/2018 | 2,327 | 61 | 62 | 101 | N/A |
6/30/2018 | 2,250 | 63 | 86 | 120 | N/A |
3/31/2018 | 2,234 | 61 | N/A | 118 | N/A |
12/31/2017 | 2,219 | 59 | N/A | 116 | N/A |
9/30/2017 | 2,184 | 59 | N/A | 99 | N/A |
6/30/2017 | 2,149 | 59 | N/A | 81 | N/A |
3/31/2017 | 2,129 | 56 | N/A | 81 | N/A |
12/31/2016 | 2,109 | 53 | N/A | 81 | N/A |
9/30/2016 | 2,152 | 52 | N/A | 73 | N/A |
6/30/2016 | 2,195 | 51 | N/A | 65 | N/A |
3/31/2016 | 2,220 | 51 | N/A | 63 | N/A |
12/31/2015 | 2,244 | 51 | N/A | 62 | N/A |
9/30/2015 | 2,164 | 52 | N/A | N/A | N/A |
6/30/2015 | 2,125 | 54 | N/A | N/A | N/A |
3/31/2015 | 2,173 | 51 | N/A | N/A | N/A |
12/31/2014 | 2,221 | 48 | N/A | 79 | N/A |
9/30/2014 | 2,303 | 41 | N/A | N/A | N/A |
6/30/2014 | 2,426 | 34 | N/A | N/A | N/A |
3/31/2014 | 2,491 | 33 | N/A | N/A | N/A |
12/31/2013 | 2,472 | 31 | N/A | 55 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: FFARM's forecast earnings growth (21.3% per year) is above the savings rate (1.2%).
Earnings vs Market: FFARM's earnings (21.3% per year) are forecast to grow faster than the Dutch market (16.2% per year).
High Growth Earnings: FFARM's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: FFARM's revenue (1.6% per year) is forecast to grow slower than the Dutch market (8.6% per year).
High Growth Revenue: FFARM's revenue (1.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: FFARM's Return on Equity is forecast to be low in 3 years time (4.3%).